Scripscan:Mavens Biotech Ltd.
cmp:100
Code:590083
Story:Mavens Biotech Limited operates as a plant biotechnology company in India. The company primarily involves in tissue culture and agri bioinformatics businesses. Its tissue culture business includes the provision of contract propagation; a range of horticulture plants, hardened plants, and bulbs; embryo culture services; somatic embryogenesis services; and protocol development and selection services, as well as keeping stock of breeding and parent lines, and mutation induction in tissue culture. The company’s agri bioinformatics business comprises the provision of various services to clients, which include DNA/protein sequence analysis; the gathering, storage, and management of specialized databanks; biological data; software development of customized analytical tools and commercial applications; and data mining. In addition, the company engages in agriculture and pharmaceutical trading businesses.Disgusting business model with so many aspects to look into.The company never came with stunning numbers and with its lethargic management neither do I expect any ever from the company.A 20crs company with less than a crore profit,dividend yield of .03%(I repeat its the dividend yield and not the brokerage for transacting it as you must be assuming) and PE of over 2000.You do know whats required here,rite folks?or you wanna own this business for a staggering 1100crs?
Search This Blog(Over 800 companies covered in the blog).
Archives : Old artciles
Friday, November 13, 2009
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
